177 related articles for article (PubMed ID: 38062659)
1. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
Tripathi D; B H MP; Sahoo J; Kumari J
Recent Adv Drug Deliv Formul; 2023 Dec; ():. PubMed ID: 38062659
[TBL] [Abstract][Full Text] [Related]
2. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
[TBL] [Abstract][Full Text] [Related]
3. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
4. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
Veith H; Wiechert F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
[TBL] [Abstract][Full Text] [Related]
5. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
Stocker MW; Healy AM; Ferguson S
Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
[TBL] [Abstract][Full Text] [Related]
6.
Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
[TBL] [Abstract][Full Text] [Related]
7. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
[TBL] [Abstract][Full Text] [Related]
8. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
[TBL] [Abstract][Full Text] [Related]
10. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance.
Pugliese A; Tobyn M; Hawarden LE; Abraham A; Blanc F
Mol Pharm; 2022 Nov; 19(11):3685-3699. PubMed ID: 36037249
[TBL] [Abstract][Full Text] [Related]
11. The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions.
Bookwala M; Wildfong PLD
Pharm Res; 2023 Dec; 40(12):2963-2981. PubMed ID: 37389801
[TBL] [Abstract][Full Text] [Related]
12. Homogeneity of amorphous solid dispersions - an example with KinetiSol
Jermain SV; Miller D; Spangenberg A; Lu X; Moon C; Su Y; Williams RO
Drug Dev Ind Pharm; 2019 May; 45(5):724-735. PubMed ID: 30653376
[TBL] [Abstract][Full Text] [Related]
13. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
14. Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.
Nambiar AG; Singh M; Mali AR; Serrano DR; Kumar R; Healy AM; Agrawal AK; Kumar D
AAPS PharmSciTech; 2022 Sep; 23(7):249. PubMed ID: 36056225
[TBL] [Abstract][Full Text] [Related]
15. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
Ojo AT; Lee PI
J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.
Jarrells TW; Munson EJ
J Pharm Sci; 2022 Oct; 111(10):2765-2778. PubMed ID: 35421430
[TBL] [Abstract][Full Text] [Related]
17. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
18. Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.
Butreddy A; Bandari S; Repka MA
Eur J Pharm Sci; 2021 Mar; 158():105655. PubMed ID: 33253883
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
Ojo AT; Ma C; Lee PI
Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
[TBL] [Abstract][Full Text] [Related]
20. Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles.
Hanada N; Higashi K; Zhao Z; Ueda K; Moribe K
Int J Pharm; 2023 Jun; 640():122959. PubMed ID: 37086931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
